Aggressive Ciliary Body Adenocarcinoma with Bilateral Lung Metastases: Histological, Molecular, Genetic and Clinical Aspects.

Ciliary body adenocarcinoma Evisceration Exenteration Lung metastasis

Journal

Ocular oncology and pathology
ISSN: 2296-4681
Titre abrégé: Ocul Oncol Pathol
Pays: Switzerland
ID NLM: 101656139

Informations de publication

Date de publication:
Feb 2019
Historique:
received: 06 12 2017
revised: 13 02 2018
entrez: 13 4 2019
pubmed: 13 4 2019
medline: 13 4 2019
Statut: ppublish

Résumé

To describe the clinical and histopathological features of an aggressive ciliary body adenocarcinoma with pulmonary metastases and skull base spread. A 45-year-old female patient presented with a post-traumatic phthisical eye that was eviscerated. This showed an unexpected carcinoma (positive for cytokeratins and melanocytic markers), the histological differential diagnosis for which included a primary ciliary body adenocarcinoma or a metastasis. The patient developed rapid post-surgical localized recurrence that required an orbital exenteration. This showed identical tumour to the evisceration specimen, with vascular invasion in orbital blood vessels and a contaminated orbital soft tissue margin. Staging imaging revealed multiple lung metastases, which were biopsied and shown to be a disseminated ciliary body adenocarcinoma rather than a disseminated primary lung carcinoma. The tumour spread locally to the skull base for which radiotherapy was given. Unfortunately, the patient passed away a few weeks later. To our knowledge, this is the first case of ciliary body adenocarcinoma with bilateral lung metastases. The malignant potential of these tumours should be considered as a possibility, and appropriate screening and staging tests should therefore be considered to guide appropriate management.

Identifiants

pubmed: 30976584
doi: 10.1159/000487805
pii: oop-0005-0079
pmc: PMC6422130
doi:

Types de publication

Journal Article

Langues

eng

Pagination

79-84

Références

Am J Ophthalmol. 2002 Sep;134(3):445-7
pubmed: 12208262
Eur J Ophthalmol. 2002 Jul-Aug;12(4):319-23
pubmed: 12220004
Ophthalmologe. 2003 Aug;100(8):618-22
pubmed: 12955442
Arch Ophthalmol. 2009 Feb;127(2):141-5
pubmed: 19204229
J Med Case Rep. 2010 Jun 19;4:185
pubmed: 20565905
Genes Chromosomes Cancer. 1990 Sep;2(3):205-9
pubmed: 2078511
Ophthalmic Plast Reconstr Surg. 2012 Sep-Oct;28(5):331-4
pubmed: 22965012
PLoS One. 2012;7(11):e50415
pubmed: 23209738
Case Rep Ophthalmol Med. 2013;2013:786378
pubmed: 23607017
Invest Ophthalmol Vis Sci. 2015 Jun;56(6):3460-6
pubmed: 26030101
Can J Ophthalmol. 2016 Apr;51(2):e67-70
pubmed: 27085283
J Fr Ophtalmol. 2017 Feb;40(2):93-101
pubmed: 28126270
Invest Ophthalmol Vis Sci. 2017 Oct 1;58(12):5445-5451
pubmed: 29059311
Arch Ophthalmol. 1968 Aug;80(2):217-9
pubmed: 5661889
Int Ophthalmol Clin. 1980 Summer;20(2):177-90
pubmed: 6995386
Ophthalmology. 1996 Dec;103(12):2007-16
pubmed: 9003334
Ophthalmology. 1997 Aug;104(8):1265-76
pubmed: 9261313
J Hepatol. 1998 Jun;28(6):1058-63
pubmed: 9672184
Ophthalmology. 1999 Jan;106(1):103-10
pubmed: 9917789

Auteurs

Konstantinos Kopsidas (K)

Sheffield Ocular Oncology Service, Department of Ophthalmology, Royal Hallamshire Hospital, Sheffield, United Kingdom.

Hardeep Mudhar (H)

National Specialist Ophthalmic Pathology Service (NSOPS), Department of Histopathology, Royal Hallamshire Hospital, Sheffield, United Kingdom.

Karen Sisley (K)

Academic Unit of Ophthalmology and Orthoptics, Department of Oncology and Metabolism, University of Sheffield, the Medical School Sheffield, Sheffield, United Kingdom.

David W Hammond (DW)

Academic Unit of Ophthalmology and Orthoptics, Department of Oncology and Metabolism, University of Sheffield, the Medical School Sheffield, Sheffield, United Kingdom.

L Worthington (L)

Academic Unit of Ophthalmology and Orthoptics, Department of Oncology and Metabolism, University of Sheffield, the Medical School Sheffield, Sheffield, United Kingdom.
Sheffield Hallam University, Sheffield, United Kingdom.

Kim Suvarna (K)

Department of Histopathology, Royal Hallamshire Hospital, Sheffield, United Kingdom.

Bernadette Foran (B)

Department of Clinical Oncology, Weston Park Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom.

Sachin Salvi (S)

Sheffield Ocular Oncology Service, Department of Ophthalmology, Royal Hallamshire Hospital, Sheffield, United Kingdom.

Classifications MeSH